Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 1
1985 1
1987 11
1988 24
1989 21
1990 20
1991 19
1992 28
1993 28
1994 33
1995 23
1996 18
1997 46
1998 24
1999 22
2000 46
2001 37
2002 40
2003 48
2004 56
2005 48
2006 56
2007 48
2008 58
2009 47
2010 73
2011 57
2012 75
2013 88
2014 115
2015 159
2016 185
2017 175
2018 179
2019 184
2020 212
2021 270
2022 86
Text availability
Article attribute
Article type
Publication date

Search Results

2,328 results
Results by year
Filters applied: . Clear all The following term was ignored: ]
Page 1
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.
Ho AL, Brana I, Haddad R, Bauman J, Bible K, Oosting S, Wong DJ, Ahn MJ, Boni V, Even C, Fayette J, Flor MJ, Harrington K, Kim SB, Licitra L, Nixon I, Saba NF, Hackenberg S, Specenier P, Worden F, Balsara B, Leoni M, Martell B, Scholz C, Gualberto A. Ho AL, et al. J Clin Oncol. 2021 Jun 10;39(17):1856-1864. doi: 10.1200/JCO.20.02903. Epub 2021 Mar 22. J Clin Oncol. 2021. PMID: 33750196 Free article. Clinical Trial.
PURPOSE: Mutations in the HRAS (mHRAS) proto-oncogene occur in 4%-8% of patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Tipifarnib is a farnesyltransferase inhibitor that disrupts HRAS function. ...
PURPOSE: Mutations in the HRAS (mHRAS) proto-oncogene occur in 4%-8% of patients with recurrent and/or metastatic (R/M) head and n
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.
Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M, Suarez C, Nixon IJ, Randolph GW, Mäkitie AA, Kowalski LP, Vander Poorten V, Sanabria A, Guntinas-Lichius O, Simo R, Zbären P, Angelos P, Khafif A, Rinaldo A, Ferlito A. Coca-Pelaz A, et al. Adv Ther. 2020 Jul;37(7):3112-3128. doi: 10.1007/s12325-020-01391-1. Epub 2020 Jun 1. Adv Ther. 2020. PMID: 32488657 Free PMC article. Review.
INTRODUCTION: Aggressive variants of papillary thyroid cancer (PTC) have been described with increasing frequency. These variants include diffuse sclerosing variant, tall cell variant, columnar cell variant, solid variant, and hobnail variant. ...
INTRODUCTION: Aggressive variants of papillary thyroid cancer (PTC) have been described with increasing frequency. These variants inc …
Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV, Foote RL, Kasperbauer JL, Bible KC. Chintakuntlawar AV, et al. Endocrinol Metab Clin North Am. 2019 Mar;48(1):269-284. doi: 10.1016/j.ecl.2018.10.010. Endocrinol Metab Clin North Am. 2019. PMID: 30717908 Review.
Anaplastic thyroid cancer (ATC) is a devastating and usually incurable diagnosis. Clinical and pathologic diagnosis is best assessed at a tertiary center with concentrated ATC expertise. ...
Anaplastic thyroid cancer (ATC) is a devastating and usually incurable diagnosis. Clinical and pathologic diagnosis is best assessed …
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ Jr, Di Cristofano A, Foote R, Giordano T, Kasperbauer J, Newbold K, Nikiforov YE, Randolph G, Rosenthal MS, Sawka AM, Shah M, Shaha A, Smallridge R, Wong-Clark CK. Bible KC, et al. Thyroid. 2021 Mar;31(3):337-386. doi: 10.1089/thy.2020.0944. Thyroid. 2021. PMID: 33728999 Free PMC article.
Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Since the guidelines for the management of ATC by the American Thyroid Association were first published in 2012, significant clinical and scientific advances have occurre …
Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Since the guidelines for the m …
Proton Therapy for Head and Neck Cancers.
Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ. Blanchard P, et al. Semin Radiat Oncol. 2018 Jan;28(1):53-63. doi: 10.1016/j.semradonc.2017.08.004. Semin Radiat Oncol. 2018. PMID: 29173756 Review.
Because of its sharp lateral penumbra and steep distal fall-off, proton therapy offers dosimetric advantages over photon therapy. In head and neck cancer, proton therapy has been used for decades in the treatment of skull-base tumors. ...
Because of its sharp lateral penumbra and steep distal fall-off, proton therapy offers dosimetric advantages over photon therapy. In head
Oral Cavity Cancer.
Ettinger KS, Ganry L, Fernandes RP. Ettinger KS, et al. Oral Maxillofac Surg Clin North Am. 2019 Feb;31(1):13-29. doi: 10.1016/j.coms.2018.08.002. Epub 2018 Oct 25. Oral Maxillofac Surg Clin North Am. 2019. PMID: 30454788 Review.
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O'Malley BW Jr, Ozer E, Thomas GR, Koch WM, Gross ND, Bell RB, Saba NF, Lango M, Méndez E, Burtness B. Ferris RL, et al. J Clin Oncol. 2022 Jan 10;40(2):138-149. doi: 10.1200/JCO.21.01752. Epub 2021 Oct 26. J Clin Oncol. 2022. PMID: 34699271 Clinical Trial.
Quality of life and swallowing were measured by functional assessment of cancer therapy-head and neck and MD Anderson Dysphagia Index. RESULTS: Credentialed surgeons performed TOS for 495 patients. ...Treatment arm distribution and oncologic outcome for ineli …
Quality of life and swallowing were measured by functional assessment of cancer therapy-head and neck and MD Anderson D …
HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features.
Bishop JA, Andreasen S, Hang JF, Bullock MJ, Chen TY, Franchi A, Garcia JJ, Gnepp DR, Gomez-Fernandez CR, Ihrler S, Kuo YJ, Lewis JS Jr, Magliocca KR, Pambuccian S, Sandison A, Uro-Coste E, Stelow E, Kiss K, Westra WH. Bishop JA, et al. Am J Surg Pathol. 2017 Dec;41(12):1690-1701. doi: 10.1097/PAS.0000000000000944. Am J Surg Pathol. 2017. PMID: 28877065 Free PMC article.
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM; American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce. Smallridge RC, et al. Thyroid. 2012 Nov;22(11):1104-39. doi: 10.1089/thy.2012.0302. Thyroid. 2012. PMID: 23130564
BACKGROUND: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Rapid evaluation and establishment of treatment goals are imperative for optimum patient management and require a multidisciplinary team approach. ...
BACKGROUND: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Rapid evaluation and establish …
ACR Appropriateness Criteria® Parathyroid Adenoma.
Expert Panel on Neurological Imaging, Zander D, Bunch PM, Policeni B, Juliano AF, Carneiro-Pla D, Dubey P, Gule-Monroe MK, Hagiwara M, Hoang JK, Jain V, Kim LT, Moonis G, Parsons MS, Rath TJ, Solórzano CC, Subramaniam RM, Taheri MR, DuChene Thoma K, Trout AT, Zafereo ME Jr, Corey AS. Expert Panel on Neurological Imaging, et al. J Am Coll Radiol. 2021 Nov;18(11S):S406-S422. doi: 10.1016/j.jacr.2021.08.013. J Am Coll Radiol. 2021. PMID: 34794597
This document summarizes the literature and provides imaging recommendations for hyperparathyroidism including primary hyperparathyroidism, recurrent or persistent primary hyperparathyroidism after parathyroid surgery, secondary hyperparathyroidism, and tertiary hyperparathyroidi …
This document summarizes the literature and provides imaging recommendations for hyperparathyroidism including primary hyperparathyroidism, …
2,328 results